These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 7310642

  • 1. Pharmacokinetics of bendroflumethiazide after low oral doses.
    Borgström L, Johansson CG, Larsson H, Lenander R.
    J Pharmacokinet Biopharm; 1981 Aug; 9(4):431-41. PubMed ID: 7310642
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of bendroflumethiazide.
    Beermann B, Groschinsky-Grind M, Lindström B.
    Clin Pharmacol Ther; 1977 Oct; 22(4):385-8. PubMed ID: 902450
    [Abstract] [Full Text] [Related]

  • 3. [Pharmacokinetic studies and bioavailability of bendroflumethiazide in combination with spironolactone].
    Vergin H, Nuss U, Strobel K.
    Arzneimittelforschung; 1986 Mar; 36(3):490-5. PubMed ID: 3707669
    [Abstract] [Full Text] [Related]

  • 4. Effect of food on the bioavailability of bendroflumethiazide.
    Beermann B, Groschinsky-Grind M, Lindström B.
    Acta Med Scand; 1978 Mar; 204(4):291-3. PubMed ID: 358763
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of bendroflumethiazide alone and in combination with propranolol and hydralazine.
    Schäfer-Korting M, Mutschler E.
    Eur J Clin Pharmacol; 1982 Mar; 21(4):315-23. PubMed ID: 7056277
    [Abstract] [Full Text] [Related]

  • 6. Does cantharides blister fluid provide access to the peripheral compartment?
    Schäfer-Korting M, Korting HC, Hiemstra S, Mutschler E.
    Eur J Clin Pharmacol; 1982 Oct; 23(4):327-30. PubMed ID: 7173302
    [Abstract] [Full Text] [Related]

  • 7. The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide.
    Sigurd B, Olesen KH, Wennevold A.
    Am Heart J; 1975 Feb; 89(2):163-70. PubMed ID: 1090132
    [Abstract] [Full Text] [Related]

  • 8. Effects on rat urinary kallikrein excretion of bumetanide, bendroflumethiazide and hydralazine.
    Nielsen K, Arrigoni-Martelli E.
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):267-72. PubMed ID: 576555
    [Abstract] [Full Text] [Related]

  • 9. Bioavailability of propranolol and bendrofluazide formulations.
    McAinsh J, Holmes BF, Baber NS, Young J.
    Biopharm Drug Dispos; 1981 Feb; 2(2):167-75. PubMed ID: 7248480
    [Abstract] [Full Text] [Related]

  • 10. Skin blister fluid--an access to the peripheral compartment. Implications of a study on the behaviour of bendroflumethiazide in rats.
    Schäfer-Korting M.
    Arzneimittelforschung; 1985 Feb; 35(12):1828-31. PubMed ID: 4096738
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Diurnal variation of urine composition in calcium oxalate stone disease during treatment with bendroflumethiazide.
    Ahlstrand C, Tiselius HG, Larsson L.
    Eur Urol; 1984 Feb; 10(4):260-5. PubMed ID: 6541131
    [Abstract] [Full Text] [Related]

  • 13. The effect of different salt intakes on exchangeable body sodium and on sodium chloride depletion during long term bendroflumethiazide administration to the normal rat.
    Steven KE, Skadjauge E.
    Acta Pharmacol Toxicol (Copenh); 1969 Feb; 27(5):349-62. PubMed ID: 5395823
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Population Pharmacokinetic-Pharmacodynamic Model of Oral Fludrocortisone and Intravenous Hydrocortisone in Healthy Volunteers.
    Hamitouche N, Comets E, Ribot M, Alvarez JC, Bellissant E, Laviolle B.
    AAPS J; 2017 May; 19(3):727-735. PubMed ID: 28083797
    [Abstract] [Full Text] [Related]

  • 19. Adequacy of twice daily dosing with potassium chloride and spironolactone in thiazide treated hypertensive patients.
    Toner JM, Brawn LA, Yeo WW, Ramsay LE.
    Br J Clin Pharmacol; 1991 Apr; 31(4):457-61. PubMed ID: 2049255
    [Abstract] [Full Text] [Related]

  • 20. [The effect of beta blockers combined with thiazides on serum electrolytes].
    Djurhuus MS, Rohold A, Vadstrup S.
    Ugeskr Laeger; 1989 Aug 14; 151(33):2076-8. PubMed ID: 2570476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.